News 2021 Innovation Challenge Finalists Announced 2021 Innovation Challenge Finalists Announced by Aisha I Abdullah PhD | February 11, 2021 Share this article: Share article via email Copy article link Lyfebulb and Bristol Myers Squibb have announced the 10 finalists who will compete virtually for a $25,000 award to support the development of innovations that address unmet needs in multiple sclerosis (MS). The Lyfebulb-Bristol Myers Squibb 2021 “Addressing Unmet Needs in MS: An Innovation Challenge” will take place March 10ā11 and will be virtual for the first time in the competitionās history. “MS is an ever-changing disease, and Bristol Myers Squibb is grateful to be partnering with Lyfebulb in supporting the entrepreneurs and creators who are looking for inventive new ways to better the lives of those who are living with this unpredictable disease,” Tina Deignan, said in a press release. Deignan is vice president and U.S. business unit head for immunology at Bristol Myers Squibb. The competition seeks to promote the development of innovative, non-therapeutic solutions to improve the health and lives of MS patients and their families while also raising awareness about MS. Every finalist is a patient entrepreneur ā an individual who either lives with MS or has a loved one with the disease ā with a company that works to advance patient-centric solutions for the MS community. The 10 MS Innovation Challenge finalists for 2021 are: Angie Conley, founder and CEO of Abilitech Medical Jason DaSilva, founder and president of AXS Lab Luanne Dibernardo, founder and CEO of Oro Sports Peter Grande, co-founder of MUVE David Hojah – CEO of Parrots Lucy Jones, founder and CEO of FFORA David Lyons, founder and director of MS Fitness Challenge Pierluigi Mantovani, CEO of Evolution Devices Tish Scolnik, co-founder and CEO of GRIT Brooke Slick, founder and product developer of Dashco “Each of these finalists is an attestation to the power of patient entrepreneurship as they have taken their hardships of living with the disease ā or observing it in a loved one ā and have turned those insights into business solutions to help other members of the MS community,” said Karin Hehenberger, MD, PhD, CEO and founder of Lyfebulb. At the virtual challenge, the finalists will pitch their innovative solutions to a panel of expert judges, including: Tim Coetzee, PhD, chief advocacy, services, and research officer at the National Multiple Sclerosis SocietyĀ Kate Cronin, global CEO of Ogilvy HealthĀ Teresa Wright-Johnson, MS patient ambassador at Lyfebulb, inspirational speaker and columnist at Multiple Sclerosis News TodayĀ Darin T. Okuda, MD, director of the Neuroinnovation Program and the Multiple Sclerosis and Neuroimmunology Imaging Program at UT Southwestern Medical Center, Dallas, Texas Stephen Squinto, PhD, executive partner at OrbiMed and co-founder of Alexion āWe are excited to bring together these inspirational leaders with our expert panel of judges and members of the Lyfebulb and Bristol Myers Squibb teams for an engaging and interactive two-day summit,ā Hehenberger said. Print This Page About the Author Aisha I Abdullah PhD Aisha Abdullah received a B.S. in biology from the University of Houston and a Ph.D. in neuroscience from Weill Cornell Medical College, where she studied the role of microRNA in embryonic and early postnatal brain development. Since finishing graduate school, she has worked as a science communicator making science accessible to broad audiences. Tags Bristol Myers Squibb, grants, Lyfebulb
April 19, 2024 News by Lindsey Shapiro, PhD AAN 2024: Long-term data support early Kesimpta start in relapsing MS
April 18, 2024 Columns by Benjamin Hofmeister Learning how to write a ‘SOAP’ note feels different after an MS diagnosis
April 18, 2024 News by Marisa Wexler, MS AAN 2024: Sustained myelin, nerve cell gains with long-term CNM-Au8